Literature DB >> 17552027

Cell culture systems for the hepatitis C virus.

Gilles Duverlie1, Czeslaw Wychowski.   

Abstract

Since the discovery of HCV in 1989, the lack of a cell culture system has hampered research progress on this important human pathogen. No robust system has been obtained by empiric approaches, and HCV cell culture remained hypothetical until 2005. The construction of functional molecular clones has served as a starting point to reconstitute a consensus infectious cDNA that was able to transcribe infectious HCV RNAs as shown by intrahepatic inoculation in a chimpanzee. Other consensus clones have been selected and established in a human hepatoma cell line as replicons, i.e. self-replicating subgenomic or genomic viral RNAs. However, these replicons did not support production of infectious virus. Interestingly, some full-length replicons could be established without adaptive mutations and one of them was able to replicate at very high levels and to release virus particles that are infectious in cell culture and in vivo. This new cell culture system represents a major breakthrough in the HCV field and should enable a broad range of basic and applied studies to be achieved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552027      PMCID: PMC4146762          DOI: 10.3748/wjg.v13.i17.2442

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Establishment of persistent hepatitis C virus infection and replication in vitro.

Authors:  S Seipp; H M Mueller; E Pfaff; W Stremmel; L Theilmann; T Goeser
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

3.  Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

Authors:  R E Lanford; C Sureau; J R Jacob; R White; T R Fuerst
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

5.  Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA.

Authors:  A A Kolykhalov; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro.

Authors:  Y K Shimizu; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro.

Authors:  S Iacovacci; A Manzin; S Barca; M Sargiacomo; A Serafino; M B Valli; G Macioce; H J Hassan; A Ponzetto; M Clementi; C Peschle; G Carloni
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

8.  Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus.

Authors:  R J Moormann; H G van Gennip; G K Miedema; M M Hulst; P A van Rijn
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus.

Authors:  T Ito; J Mukaigawa; J Zuo; Y Hirabayashi; K Mitamura; K Yasui
Journal:  J Gen Virol       Date:  1996-05       Impact factor: 3.891

10.  A novel sequence found at the 3' terminus of hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-10-13       Impact factor: 3.575

View more
  8 in total

1.  Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.

Authors:  Mayura M Desai; Batbayar Tumurbataar; Yueqing Zhang; Lee-Nien Lillian Chan; Jiaren Sun; Teh-Sheng Chan
Journal:  Transgenic Res       Date:  2011-02-24       Impact factor: 2.788

2.  Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells.

Authors:  S Choi; B Sainz; P Corcoran; S Uprichard; H Jeong
Journal:  Xenobiotica       Date:  2009-03       Impact factor: 1.908

Review 3.  Scotomas in molecular virology and epidemiology of hepatitis C virus.

Authors:  Yue Wang
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

4.  Glances in Immunology of HIV and HCV Infection.

Authors:  Maria Giovanna Quaranta; Benedetta Mattioli; Stefano Vella
Journal:  Adv Virol       Date:  2012-06-07

5.  Antiviral activity of Bacillus sp. isolated from the marine sponge Petromica citrina against bovine viral diarrhea virus, a surrogate model of the hepatitis C virus.

Authors:  Juliana Cristina Santiago Bastos; Luciana Konecny Kohn; Fabiana Fantinatti-Garboggini; Marina Aiello Padilla; Eduardo Furtado Flores; Bárbara Pereira da Silva; Cláudia Beatriz Afonso de Menezes; Clarice Weis Arns
Journal:  Viruses       Date:  2013-04-29       Impact factor: 5.048

6.  Baculovirus expression of cloned porcine arterivirus generates infectious particles in both insect and mammalian cells.

Authors:  Hao Zheng; Changlong Liu; Jinshan Zhuang; Shishan Yuan
Journal:  J Biotechnol       Date:  2010-08-20       Impact factor: 3.307

7.  Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine.

Authors:  Hemshankar Laugi
Journal:  Euroasian J Hepatogastroenterol       Date:  2020 Jul-Dec

Review 8.  COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!

Authors:  Mohammad S Khuroo; Mohammad Khuroo; Mehnaaz S Khuroo; Ahmad A Sofi; Naira S Khuroo
Journal:  J Clin Exp Hepatol       Date:  2020-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.